Variance component analysis of circulating miR-122 in serum from healthy human volunteers

• Published in: PloS one 2019-07, Vol.14 (7), p.e0220406-e0220406
• Main Authors: Vogt, Jennifer, Sheinson, Daniel, Katavolos, Paula, Irimagawa, Hiroko, Tseng, Min, Alatsis, Kathila R, Proctor, William R
• Format: Article
• Language: English
• Subjects: Adaptive algorithms; Adaptive control; Adult; Alanine; Alanine transaminase; Algorithms; Analgesics; Biological markers; Biology and life sciences; Biomarkers; Biomarkers - blood; Breast cancer; Caenorhabditis elegans; Carcinoma; Care and treatment; Chronic active hepatitis; Clinical trials; Confidence; Continental Population Groups - genetics; Correlation analysis; Disease control; Female; Genes; Genetic aspects; Genetic Heterogeneity; Healthy Volunteers; Hepatitis; Hepatocellular carcinoma; Humans; Injuries; Liver; Liver cancer; Liver diseases; Longitudinal Studies; Male; Medical research; Medicine and Health Sciences; Metabolism; Metastasis; MicroRNA; MicroRNAs; MicroRNAs - blood; Middle Aged; Minority & ethnic groups; miRNA; People and Places; Physical Sciences; Polymerase chain reaction; Prospective Studies; Proteins; Real-Time Polymerase Chain Reaction - standards; Reference Standards; Research and Analysis Methods; Ribonucleic acid; RNA; Variability; Variance analysis
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0220406

Micro-RNA (miR)-122 is a promising exploratory biomarker for detecting liver injury in preclinical and clinical studies. Elevations in serum or plasma have been associated with viral and autoimmune hepatitis, non-alcoholic steatohepatitis (NASH), hepatocellular carcinoma, and drug-induced liver injury (DILI). However, these associations were primarily based upon population differences between the disease state and the controls. Thus, little is known about the variability and subsequent variance components of circulating miR-122 in healthy humans, which has implications for the practical use of the biomarker clinically. To address this, we set out to perform variance components analysis of miR-122 in a cohort of 40 healthy volunteers. Employing a quantitative real-time polymerase chain reaction (qRT-PCR) assay to detect miR-122 and other circulating miRNAs in human serum, the relative expression of miR-122 was determined using two different normalization approaches: to the mean expression of a panel of several endogenous miRNAs identified using an adaptive algorithm (miRA-Norm) and to the expression of an exogenous miRNA control (Caenorhabditis elegans miR-39). Results from a longitudinal study in healthy volunteers (N = 40) demonstrated high variability with 117- and 111-fold 95% confidence reference interval, respectively. This high variability of miR-122 in serum appeared to be due in part to ethnicity, as 95% confidence reference intervals were approximately three-fold lower in volunteers that identified as Caucasian relative to those that identified as Non-Caucasian. Variance analysis revealed equivalent contributions of intra- and inter-donor variability to miR-122. Surprisingly, miR-122 exhibited the highest variability compared to other 36 abundant miRNAs in circulation; the next variable miRNA, miR-133a, demonstrated a 45- to 62-fold reference interval depending on normalization approaches. In contrast, alanine aminotransferase (ALT) activity levels in this population exhibited a 5-fold total variance, with 80% of this variance due to inter-donor sources. In conclusion, miR-122 demonstrated higher than expected variability in serum from healthy volunteers, which has implications for its potential utility as a prospective biomarker of liver damage or injury.